Evogene Ltd.
EVGN· Nasdaq
EVGNEvogene Ltd.
Who holds Evogene Ltd., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 80.1K | New | $33.9K | 0% | Aug 14, 2026 |
| Citadel Advisors LLC | 50.5K | New | $21.4K | 0% | Sep 2, 2026 |
| XTX Topco Ltd | 19.4K | +52.5% | $8.2K | 0.1% | Aug 14, 2026 |
| UBS Group AG | 10.8K | +69.9% | $4.7K | 0% | Aug 13, 2026 |
| Daytona Street Capital LLC | 9.3K | −3.5% | $4.7K | 0.1% | Aug 3, 2026 |
| BNP Paribas Financial Markets | 2.8K | −69.0% | $1.2K | 0% | Aug 13, 2026 |
| Morgan Stanley | 1.3K | −66.6% | $564 | 0% | Aug 13, 2026 |
| Federation des caisses Desjardins du Quebec | 500 | ±0% | $220 | 0% | Aug 14, 2026 |
| HRT Financial LP | 107.2K | New | $45 | 0.1% | Aug 14, 2026 |
| Osaic Holdings, Inc. | 100 | ±0% | $44 | 0% | Aug 14, 2026 |
| SHP Wealth Management | 65 | ±0% | $29 | 0% | Aug 11, 2026 |
| SBI Securities Co., Ltd. | 62 | −13.9% | $27 | 0% | Jul 23, 2026 |
| Citigroup Inc | 0 | ±0% | $0 | 0% | Aug 3, 2026 |
| Royal Bank of Canada | 42 | ±0% | $0 | 0% | Aug 14, 2026 |
